Howard Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.97M | Buy |
8,918
+2,282
| +34% | +$1.02M | 0.06% | 105 |
|
2025
Q1 | $3.22M | Sell |
6,636
-1,021
| -13% | -$495K | 0.08% | 102 |
|
2024
Q4 | $3.08M | Buy |
7,657
+224
| +3% | +$90.2K | 0.05% | 111 |
|
2024
Q3 | $3.46M | Buy |
+7,433
| New | +$3.46M | 0.06% | 102 |
|
2020
Q4 | – | Sell |
-1,859
| Closed | -$506K | – | 65 |
|
2020
Q3 | $506K | Sell |
1,859
-761
| -29% | -$207K | 0.12% | 40 |
|
2020
Q2 | $768K | Buy |
+2,620
| New | +$768K | 0.22% | 26 |
|
2020
Q1 | – | Sell |
-4,979
| Closed | -$726K | – | 48 |
|
2019
Q4 | $726K | Buy |
4,979
+3,472
| +230% | +$506K | 0.25% | 17 |
|
2019
Q3 | $255K | Buy |
1,507
+5
| +0.3% | +$846 | 0.11% | 36 |
|
2019
Q2 | $254K | Sell |
1,502
-127
| -8% | -$21.5K | 0.11% | 35 |
|
2019
Q1 | $310K | Buy |
+1,629
| New | +$310K | 0.16% | 35 |
|